Experience in the study of a live vaccine made from the TP-21 strain of Malayan Langat virus.
The reaction-causing properties and immunogenicity of 2 cloned variants of the Malayan tick virus, Langat TP-21 strain, were studied. One clone, which was not pathogenic for rhesus monkeys when inoculated intracerebrally, caused the formation of antibody in moderate titre against tick-borne encephalitis virus in over 70% of persons given 2 inoculations of a live vaccine prepared from it. The other variant, which was pathogenic for rhesus monkeys, was characterized by greater immunogenicity but when given as a live vaccine caused acutely febrile reactions and other side-effects in 10% of inoculated persons 6 to 8 days after administration.In persons vaccinated with the avirulent vaccine, the antibodies were maintained for over 3 years compared with only 1 year after administration of a killed vaccine. The live vaccine made from the non-pathogenic clone of the Langat virus proved to be suitable for revaccinating patients inoculated with the killed vaccine. The vaccine prepared from the non-pathogenic clone could be more extensively employed for the prophylaxis of tick-borne encephalitis.
D004675:Encephalitis, Tick-Borne / Q000517:prevention & control*; D006801:Humans; D014611:Vaccination; D014765:Viral Vaccines
D014765:Viral Vaccines